BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10878390)

  • 1. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
    Jones ND; Van Maurik A; Hara M; Spriewald BM; Witzke O; Morris PJ; Wood KJ
    J Immunol; 2000 Jul; 165(2):1111-8. PubMed ID: 10878390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
    Honey K; Cobbold SP; Waldmann H
    J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
    Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
    J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
    Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
    J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
    J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
    Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
    Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
    Chen Y; Heeger PS; Valujskikh A
    J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
    Burrell BE; Lu G; Li XC; Bishop DK
    J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
    J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance.
    Filatenkov AA; Jacovetty EL; Fischer UB; Curtsinger JM; Mescher MF; Ingulli E
    J Immunol; 2005 Jun; 174(11):6909-17. PubMed ID: 15905533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.